Skip to content

Monitoring of finger blood flow in patients who have developed a worsening of renal function due to a generalized infection

Monitoring peripheral perfusion in Sepsis associated acute kidney injury: prognostic, temporal evolution and fluid balance analysis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-72v646
Enrollment
Unknown
Registered
2019-12-27
Start date
2019-02-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic, acute renal injury

Interventions

141 patients selected for the study (113 patients in the group with acute kidney injury and 28 without acute kidney injury) will be evaluated after hemodynamic resuscitation using capillary filling ti
Device
Other

Sponsors

Hospital das clínicas da Ufpr
Lead Sponsor
Hospital das clínicas da Ufpr
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Sepsis patients

Exclusion criteria

Exclusion criteria: Pregnance; Dialitic Cronic kidney injury; Not avalible peripheral perfusion; Patient refusal

Design outcomes

Primary

MeasureTime frame
To evaluate the prevalence of peripheral hypoperfusion using the peripheral perfusion index and capillary filling time in patients with sepsis with and without acute renal injury;To evaluate the incidence of in-hospital mortality, observed within 28 days, associated with peripheral hypoperfusion in patients with sepsis-associated with acute renal injury.

Secondary

MeasureTime frame
Serial evaluation of the peripheral perfusion index for 72 hours in patients with acute renal injury in relation to mortality outcomes;To evaluate the correlation of the water balance with the peripheral perfusion index

Countries

Brazil

Contacts

Public ContactANA;ANA DE MIRANDA;DE MIRANDA

Hospital das clínicas da Ufpr;Hospital das clínicas da Ufpr

miranda.anacarolina@gmail.com;miranda.anacarolina@gmail.com55-041-96772585;55-041-96772585

Outcome results

None listed

Source: REBEC (via WHO ICTRP)